chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Subsequently pt developed an injection site reaction characterized by redness extending from the shoulder to elbow, swelling and warmth. The patient recovered. This is 6 patients from this facility who developed and reaction.
HEAD ACHE; FEVER; BODY ACHE; TENOSYNOVITIS; CHILLS; ANKLE PAIN; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 02-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, the subject experienced body ache. On APR-2021, the subject experienced tenosynovitis. On APR-2021, the subject experienced chills. On APR-2021, the subject experienced ankle pain. On 02-APR-2021, Laboratory data included: Body temperature (NR: not provided) 103 F. On 04-APR-2021, the subject experienced fever. On 07-APR-2021, the subject experienced head ache. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, body ache, head ache, chills, ankle pain and tenosynovitis was not reported. This report was non-serious.
I had all the normal symptoms to be expected with a vaccine, slight fever, headache and body pain. That's not my concerning part. My left arm is all red and swollen around the injection site: 1½-inch wide by 1-inch long and getting bigger. I have taken pictures of it (if you'd like them).
Client scheduled to received MPX JYNNESOS vaccine today Friday RN, PHN, MPX Nurse Manager  9/16/2022. 9/16/2022,at the Clinic. He was registered at the front desk, the client entered the vaccination room with the RNvaccinator RN and RN, PHN , MPX Nurse Manager/ Patient was asked if this was his first or second dose, he replied "this is my second dose". When asked when was his last dose and if he had his record, he said " I don't have the paper but it was in August. Patient also did not wait in the post observation area as directed. It was later discovered by pod site manager, that the client had received his first dose last Sunday 9/11/22 at the event.
cough, nasal congestion, body aches, congestion in my chest, dizziness , nausea etc. at times a little vertigo.
(1) - (L) vein in neck (collarbone, above) was pounding and heart beat fast (took meds listed in #17) then subsided a little in (1) one HR. (2) - morning after 10/30/08 noticed (L) arm w/ tape at site of injection to date still black/blue (bruised).
received vaccine while 36 weeks pregnant; This spontaneous prospective pregnancy case was reported by a physician and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (received vaccine while 36 weeks pregnant) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Pregnant.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (received vaccine while 36 weeks pregnant). At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (received vaccine while 36 weeks pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator  No treatment medications provided by the reporter.; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this female patient. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
pt recvd vax;devel hives, red raised area on inject arm, itching;shortness of breath & chest pain;
This spontaneous report as received from a pharmacist refers to a 76 year old female patient with none drug reactions or allergies. The patient's medical history included shingles which damaged eyesight and hemorrhoids. On 19-NOV-2013 the patient was vaccinated with the dose of ZOSTAVAX (lot number: J011212, expiration date 29-AUG-2014), injections (route and strength not provided). Concomitant therapies included hydrocortisone suppositories. On 20-NOV-2013 the patient experienced red rash around injection site the size of a silver dollar. On 22-NOV-2013 the patient called the pharmacist and reported that "now" the whole back of her (same arm as ZOSTAVAX was administered) was red but not blistery. The patient sought medical attention and called physician. None treatment was given for adverse event. No lab diagnostics studies were performed. The pharmacist noted that the patient will be seeing her primary care physician at the day of report. The outcome of whole back of her arm was red and red rash around injections site was reported as not recovered/not resolved. The relatedness between vaccination with ZOSTAVAX and whole back of her arm was red and red rash around injections site was not reported. Additional information has been requested.
still having bad dizzy spells; This spontaneous case was reported by a patient and describes the occurrence of DIZZINESS (still having bad dizzy spells) in a 66-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis. Concurrent medical conditions included Diabetic. Concomitant products included INFLUENZA VACCINE for an unknown indication.    On 18-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In October 2022, the patient experienced DIZZINESS (still having bad dizzy spells). At the time of the report, DIZZINESS (still having bad dizzy spells) had not resolved. The patient received booster along with the flu shot on Tuesday and patient still had bad dizzy spells. Patient was asking if it was normal 5 days after vaccination. No treatment information was reported.
Prolonged vaginal bleeding- patient does not have periods with her Nexplanon, started bleeding after 2nd dose Moderna 5 weeks ago and has not stopped.
pt recv vax 19996 7 APR97 pt devel a mild case of chickenpox consisting of a few vesicular lesions on face & trunk;
This case was reported by a other health professional via sales rep and described the occurrence of swelling in a adult patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced swelling. On an unknown date, the outcome of the swelling was unknown. It was unknown if the reporter considered the swelling to be related to SHINGRIX. Additional details were provided as follows: This case was reported by a vaccine coordinator. The age at vaccination was not reported. The age group was not reported, but was selected as adult as per vaccine indication. The healthcare professional reported about the patient who, upon receiving the SHINGRIX vaccine experienced severe swelling. The reporter agreed to follow up. This incident was originally reported by a physician. This case was linked with US2018GSK112760, reported by the same reporter.
Patient complained of tingling mouth, throat and tongue. Administered 10 mg Cetirizine orally per Doctor at 1255. Patient stated feeling better 1305. Patient released at 1308 per doctor.
Patient received the Moderna COVID-19 vaccine today at our pharmacy and on the way to the waiting chair she came up to the pharmacy counter and started to say that she felt a little nauseous. She then fainted and I rushed up to the counter and she was already sitting up, very pale. When she was ready we helped her up to the waiting chair and gave her a bottle of water. Her mother was with her to care for her. She waited almost a half hour and felt fine so they both left. She did mention that she was afraid of needles so potentially she could've been thinking about that when she fainted.
fever x 1 wk 101-102 today 15SEP94 105.5; 16SEP phone call to mom-no fever;
Large area of redness to left upper arm at injection site that I have recently seen described as "covid arm".
after each vaccine my platelet count went down into the 20000 range; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 21Apr2021 11:45 (Lot number: ER8731) at the age of 74 years as dose 2, single and intramuscular, administered in arm left, administration date 31Mar2021 11:45 (Lot number: ER8733) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Thrombocytopenia", start date: 2019 (ongoing), notes: Pertinent details: Rituximab Infusions 01Mar2021- 08Mar2021- 15Mar2021, 22Mar2021 (All in Mar2021). The patient's concomitant medications were not reported.  The following information was reported: PLATELET COUNT DECREASED (non-serious), outcome "unknown", described as "after each vaccine my platelet count went down into the 20000 range". The event "after each vaccine my platelet count went down into the 20000 range" was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of platelet count decreased.  Additional information: ThPlatelet factor IV after each vaccine my platelet count went down into the 20,000 range at which point the hematologist prescribed prednisolone which would bring the platelet count up somewhat around the 50,000 range.  No follow-up attempts are possible. No further information is expected.
On October 22 I got my period so I should not have gotten my next period until around November 22. Today, 6 hours after getting my booster shot I started menstrual bleeding again. I am pretty regular and usually get my period around the same time each month. I am not overly concerned, but felt it should be noted so further research can be done about irregular menstrual bleeding.
Redness; Itchiness; Swollen Lymph Nodes; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE PRURITUS (Itchiness) and LYMPHADENOPATHY (Swollen Lymph Nodes) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historical condition was reported). Concomitant products included INSULIN, METFORMIN, LISINOPRIL and ATORVASTATIN for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE PRURITUS (Itchiness) and LYMPHADENOPATHY (Swollen Lymph Nodes). At the time of the report, VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE PRURITUS (Itchiness) and LYMPHADENOPATHY (Swollen Lymph Nodes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
-developed what my internist diagnosed as a mild case of shingles when she saw red blotches on my lower right back just before i was due for my 2nd covid vaccine, but the related nerve pain, which i could not identify until the blisters began to appear,, started approx 2 weeks after my 1st covid vaccine.  -i did not take any antiviral medications because of concerns about counteracting effectiveness of the vaccine. -the shingles intensified after 2nd covid vaccine, but have since largely resolved.
MILD FATIGUE; HEADACHE; INJECTION SITE SORE TO PRESSURE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination.  The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the subject experienced mild fatigue, headache, and injection site sore to pressure. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from injection site sore to pressure, and the outcome of mild fatigue and headache was not reported. This report was non-serious.
15 years and 6 month old female patient  presented to our office after being administered Moderna Covid vaccine at pharmacy. No adverse side effects noticed. Mom gave us vaccine card with Wrong first name, correct last name and DOB.
pt recvd vax & w/in 24 hrs pt devel redness, induration, swelling, & warmth @ site of inj;
Discombobulated; I was hanging up against wall; My equilibrium was completely off; the headache got on my left side, It's sharp as somebody hit you with a nail; I have been taking 2-3 hours nap and that's not me; He was afraid. He cannot explain it, he can take pain,  but with vaccine he couldn't even open the eyes; This is a spontaneous report from a contactable consumer.  A 74-year-old male consumer reported that he received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number unknown), into the left upper arm on 22Mar2021 (at the age of 74years-old) at single dose for COVID-19 immunization. Medical history included high cholesterol and 'prostate'.  Concomitant drugs included  Flomax 0.4 mg for prostate, one a day, Simvastatin 40 mg once daily for High Cholesterol and Clonazepam 2 mg for sleep for years. The patient reported that he received first dos of vaccine and the next day was discombobulated. He was hanging up against wall. His equilibrium was completely off that got better little bit but he was still wobbly but the headache got on his left side, he felt like he was having a stroke and he still has a headache that comes and goes, it was sharp as somebody hit you with a nail and he just does not know if he should take second shot or not since he was afraid. ''He cannot explain it, he can take pain,  he had done operations (Clarification unknown) and everything but with vaccine he couldn't even open the eyes, his equilibrium was so off and sleeps, he has been taking 2-3 hours nap and that's not him."   As per treatment, the only thing they gave him was Aspirin or Advil. He tried Tylenol and it did not work and he tried everything and then he tried Sinutab and he tried Motrin, he tried everything. At the time of reporting the patient had not recovered.   Information on the lot/batch number has been requested.
Pt's right upper arm was red, swollen and hot to the touch. Pneumococcal injection given in right deltoid on 10/16/01. Pain in arm started on evening of 10/16/01.
Treatment of COVID-19; Treatment of COVID-19; patient previously received dose 3 of Moderna vaccine; patient previously received dose 3 of Moderna vaccine; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61-year-old male patient received BNT162b2 (BNT162B2), on 19Apr2022 as dose 4 (booster), single (Lot number: FK9895) at the age of 61 years, in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 16Nov2021 as dose 3 (booster), single (Lot number: 034F21A), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: OFF LABEL USE (medically significant), INTERCHANGE OF VACCINE PRODUCTS (medically significant) all with onset 19Apr2022, outcome "unknown" and all described as "patient previously received dose 3 of Moderna vaccine"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19 included paxlovid.
Information has been received from the authors in a literature article concerning a 6 year old male patient who was vaccinated with PCV (23-valent) (manufacturer unknown). No concomitant vaccines were reported. The 6 year old boy with sickle cell disease type hemoglobin SC SCD was brought to the emergency department with left thigh pain and swelling 9 hours after PPSV23 (manufacturer unknown) administration. He was febrile (38.7 degrees C), with a WBC (white blood cell) count of 12.4 x 1000/mm3 that showed leukocytosis on admission (8.9 x 1000/mm3 before immunization). The patient was admitted and received penicillin and clindamycin. He was afebrile throughout his hospitalization and was discharged 4 days later when the swelling completely resolved. This is one of several reports from the same literature (1506USA012954, 1506USA013114, 1506USA013112 and 1506USA013113). Additional information has been requested.
Hives starting on the right forearm and proceeded to other parts. Excessive bruising on the left forearm and proceeded to other parts.
Pt received SHINGRIX vaccine 3 days ago (9/11/18). Came in 9/14/18 and reported redness at injection site-red area got bigger with each day. Pt reported itchy feeling, warm to touch, some dizziness. Red color decreased from 9/13 to 9/14. Seemed to be improving and less red. This was the second dose in the series. Felt worse at night.
Swollen feeling in arm, saw Dr. Doctor treated patient for muscle spasms in back.  On Nov 16, pt reports still do not have proper feeling in thumb and tingling off and on down arm.
nausea, chest pain, shortness of breath, paralysis from shoulders down through lower extremities
FLU VACCINE - which is administered on the same date as Pfizer vaccine; FLU VACCINE - which is administered on the same date as Pfizer vaccine; Shivers; Mild temperature started; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 55-year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 29Sep2021 12:15 (Lot number: EW0217) at the age of 55 years as dose 3 (booster), single for covid-19 immunisation; influenza vaccine (FLU VACCINE VII), administered in arm right, administration date 29Sep2021 (Batch/Lot number: unknown) as dose 1, single. The patient had no relevant medical history. Concomitant medication(s) included: FLOVENT. Vaccination history included: Bnt162b2 (1st dose), when the patient was 55 years old, for Covid-19 immunization; Bnt162b2 (2nd dose), when the patient was 55 years old, for Covid-19 immunization. The following information was reported: OFF LABEL USE (non-serious), PRODUCT USE ISSUE (non-serious) all with onset 29Sep2021, outcome "unknown" and all described as "FLU VACCINE - which is administered on the same date as Pfizer vaccine"; CHILLS (non-serious) with onset 29Sep2021, outcome "recovering", described as "Shivers"; PYREXIA (non-serious) with onset 29Sep2021, outcome "recovering", described as "Mild temperature started". Therapeutic measures were not taken as a result of chills, pyrexia.  Additional information: 11-12 hours post booster shot, shivers and mild temperature started. this lasted on and off through next 24 hours. This case assessed as non-serious by the reporter. No hospitalization Prolonged. Facility where the most recent COVID-19 vaccine was administered at Workplace clinic. Flovent received within 2 weeks of vaccination. Patient not diagnosed with covid-19 prior to vaccination and since vaccination patient not tested for covid-19.  Follow-up attempts are completed. No further information is expected.
One week after injection a red, somewhat itchy rash approximately 5 cm in diameter appeared on my arm at the site of injection.
Hives increasing all over my body.  They started on my right arm and chest and worsened over the course of the day.  I took a Benadryl and that helped the inflammation.  The rash then showed up on my ears and left arm and hand and became much worse on my chest and right arm.  It has currently spread to my legs and in my scalp area.
Tested positive for COVID-19 on December 30; cough, fatigue, headache, very tired and wanted to sleep all day.  Cough developed on 12/26.  Symptoms resolved on 01/02. Isolated for 5 days.
Resident developed a red rah on chest, neck and back approximately 6 hours after receiving vaccination
pt recvd vax 19JUL94 & exp gen achiness in arms & legs, malaise, chills, low grade fever, chest tightness &  h/a;22JUL94 presented to MD;exam revealed palpable tenderness of the costochondral junction;WBC count 17.1 & inc IgE of 580;
vomiting; diarrhea; severe chills; headache; Last night I had everything were horrible; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558). The reporter is the patient.  A 70 year-old female patient received bnt162b2 (BNT162B2), administration date 02Mar2021 09:30 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (first dose of Pfizer-BioNTech COVID-19 Vaccine), administration date: 09Feb2021, for Covid-19 immunisation. The following information was reported: VOMITING (non-serious) with onset 04Mar2021, outcome "recovered" (Mar2021), described as "vomiting"; DIARRHOEA (non-serious) with onset 04Mar2021, outcome "recovered" (Mar2021), described as "diarrhea"; CHILLS (non-serious) with onset 04Mar2021, outcome "recovered" (Mar2021), described as "severe chills"; HEADACHE (non-serious) with onset 04Mar2021, outcome "not recovered", described as "headache"; FEELING ABNORMAL (non-serious) with onset 04Mar2021, outcome "unknown", described as "Last night I had everything were horrible".  Additional information: She reported: "last night (around two and a half days later) I had symptoms/reaction; I had vomiting, diarrhea, severe chills, and a headache". Did not attempt warm transfer to Safety because caller stated she still had the headache (all other symptoms had resolved, except for headache) and to avoid her from waiting too long on hold, due to high call volume. Transferring agent stated, "I have a caller here on the other line and she received the second dose on Tuesday, (02Mar2021). She mentioned that she experienced chills, vomiting, diarrhea and headache after receiving the second dose." When paraphrased the concern to confirm, consumer transferring agent stated, "Yes, chills, vomiting, diarrhea and headache." When paraphrased the concern, consumer stated, "Yes, I mean, I had it during the night, I had it like since the vaccine is on Tuesday, so was during the night, last night I had everything the headache, the vomiting, the diarrhea and chills were horrible but that's okay I just have a remaining like headache, I just want see was it normal, you guys expect (incomplete sentence), I have a reaction. I could have a reaction within the 24 hours."  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.